Showing results (81-90 of 1,007) with videos related to
Sort By:
Pageof 101
Thrombosis Journal|September 29, 2006
Preparation of platelet-rich plasma as a tissue adhesive for experimental transplantation in rabbitsFederico Luengo Gimeno, Silvia Gatto, José Ferro, et al.Thrombosis Journal|June 23, 2009
Thrombotic genetic risk factors and warfarin pharmacogenetic variants in São Miguel's healthy population (Azores)Claudia C Branco, Tânia Pereirinha, Rita Cabral, et al.Thrombosis Journal|July 23, 2009
Annexin V and anti-Annexin V antibodies: two interesting aspects in acute myocardial infarctionMohammad Shojaie, Abdoreza Sotoodah, Shohre Roozmeh, et al.Thrombosis Journal|May 7, 2010
Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetesTrine B Opstad, Alf Age Pettersen, Thomas Weiss, et al.Thrombosis Journal|June 23, 2010
Postpartal recurrent non-ST elevation myocardial infarction in essential thrombocythaemia: case report and review of the literatureSpyridon Arampatzis, Ioannis Stefanidis, Vassilios Lakiopoulos, et al.Thrombosis Journal|October 12, 2011
Using highly variable warfarin dosing to identify patients at risk for adverse eventsLyndonna Marrast, Mary Evans, Al Ozonoff, et al.Thrombosis Journal|July 29, 2011
Battle of oral anticoagulants in the field of atrial fibrillation scrutinized from a clinical practice (the real world) perspectiveRaul Altman, Hector O VidalThrombosis Journal|May 17, 2011
EMILIN2 (Elastin microfibril interface located protein), potential modifier of thrombosisQila Sa, Jane L Hoover-PlowThrombosis Journal|December 22, 2016
Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratoriesA Magnette, M Chatelain, B Chatelain, et al.Thrombosis Journal|September 7, 2013
The new oral anti-coagulants and the phase 3 clinical trials - a systematic review of the literatureFaryal Tahir, Haris Riaz, Talha Riaz, et al.Pageof 101